Article
Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study.
The Korean journal of internal medicine - 1 Sept 2020
Jeong Jae Yoon, Jun Dae Won, Park Sol Ji, Sohn Joo Hyun, Kim Sang Gyune, Lee Se Whan, Jeong Soung Won, Kim Moon Young, Kim Won, Shim Jae-Jun, Kim Hyoung Su, Suk Ki Tae, Ahn Sang Bong
Abstract excerpt
BACKGROUND/AIMS: We aimed to assess the role of vitamin D supplementation in the response to pegylated interferon-α (PEG-IFN-α) plus ribavirin (RBV) treatment in patients with chronic hepatitis C (CHC). METHODS: Our study was a multi-center, randomized controlled trial in 11 hospitals. CHC patients were randomly assigned (1:1) to two groups namely, PEGIFN-α plus RBV (control group) or PEG-IFN-α plus RBV + vitamin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
